| Dr Matthew Asperin Nacpil, DO | |
|
10030 Gilead Rd, Huntersville, NC 28078-7545 | |
| (704) 316-3789 | |
| (704) 316-6785 |
| Full Name | Dr Matthew Asperin Nacpil |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 7 Years |
| Location | 10030 Gilead Rd, Huntersville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679093199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 227441 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Medical Group Inc | 1153234893 | 1996 |
News Archive
A combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor, axitinib, significantly improves progression-free survival in previously untreated patients with advanced renal cell carcinoma in a phase 3 study, according to results presented at ESMO 2018 Congress.
A protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.
› Verified 2 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
A combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor, axitinib, significantly improves progression-free survival in previously untreated patients with advanced renal cell carcinoma in a phase 3 study, according to results presented at ESMO 2018 Congress.
A protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Asperin Nacpil, DO Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 316-3789 | Dr Matthew Asperin Nacpil, DO 10030 Gilead Rd, Huntersville, NC 28078-7545 Ph: (704) 316-3789 |
News Archive
A combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor, axitinib, significantly improves progression-free survival in previously untreated patients with advanced renal cell carcinoma in a phase 3 study, according to results presented at ESMO 2018 Congress.
A protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.
The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.
The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.
› Verified 2 days ago
Chandrasekhar Kothagundla, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-3789 Fax: 704-316-6785 | |
Dr. Charlie Isaiah Ervin Ii, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-316-3789 | |
Tolshala Tenesha Gates, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10030 Gilead Rd, Huntersville, NC 28078 Phone: 704-384-5416 Fax: 704-384-5992 |